Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Shugoshin-like protein 2 (SGO2) is a conserved chromosomal protein that plays an essential role in meiotic and mitotic chromosome segregation in eukaryotes. It belongs to the Shugoshin/Mei-S322 family, and its primary function is to maintain sister chromatid cohesion at centromeres, protect the cohesin complex during cell division, and recruit the chromosomal passenger complex (CPC) to specific chromatin domains. SGO2 localizes to centromeres and subtelomeric chromatin, regulating the spindle assembly checkpoint, promoting correct kinetochore-microtubule attachments, and contributing to the formation of highly condensed chromatin at subtelomeres in yeasts and mammals. Loss of SGO2 leads to errors in chromosome biorientation or premature chromatid separation, resulting in infertility in mice and increased risk of chromosomal instability and aneuploidy. While SGO2 is crucial for cell division and genomic integrity, it is not currently a therapeutic target nor a biomarker for disease or therapy monitoring.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Shugoshin-like protein 2 (SGO2).